Early outcomes using hepatitis c-positive donors for cardiac transplantation in the era of effective direct-acting antiviral therapies

Given the shortage of suitable donor hearts for cardiac transplantation, and the favorable safety and efficacy of current agents used to treat hepatitis C (HCV), our institution recently piloted transplantation of selected patients using HCV-positive donors.

Source: The Journal of Heart and Lung Transplantation - January 21, 2018 Category: Transplant Surgery Authors: Kelly H. Schlendorf, Sandip Zalawadiya, Ashish S. Shah, Mark Wigger, Chan Y. Chung, Sarah Smith, Matthew Danter, Chun W. Choi, Mary E. Keebler, D. Marshall Brinkley, Suzanne Brown Sacks, Henry Ooi, Roman Perri, Joseph A. Awad, Samuel Lewis, Rachel Hayes, Source Type: research